These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 15532987

  • 1. Pneumococcal conjugate vaccines--a European perspective.
    Reinert RR.
    Int J Med Microbiol; 2004 Oct; 294(5):277-94. PubMed ID: 15532987
    [Abstract] [Full Text] [Related]

  • 2. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR.
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [Abstract] [Full Text] [Related]

  • 3. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ, McIntosh ED, Reinert RR.
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [Abstract] [Full Text] [Related]

  • 4. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ.
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
    Weil-Olivier C, Gaillat J.
    Vaccine; 2014 Apr 11; 32(18):2022-6. PubMed ID: 24565755
    [Abstract] [Full Text] [Related]

  • 8. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S, van der Linden M, Siedler A, von Kries R.
    Klin Padiatr; 2011 Mar 11; 223(2):61-4. PubMed ID: 21271500
    [Abstract] [Full Text] [Related]

  • 9. The safety of 7-valent pneumococcal conjugate vaccine.
    Ghaffar F.
    Expert Opin Drug Saf; 2005 Jul 11; 4(4):631-6. PubMed ID: 16011442
    [Abstract] [Full Text] [Related]

  • 10. The future of pneumococcal disease prevention.
    Rodgers GL, Klugman KP.
    Vaccine; 2011 Sep 14; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [Abstract] [Full Text] [Related]

  • 11. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N, Micone P, Gentile A.
    Vaccine; 2011 Sep 14; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [Abstract] [Full Text] [Related]

  • 12. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
    Prescrire Int; 2002 Feb 14; 11(57):7-10. PubMed ID: 11985376
    [Abstract] [Full Text] [Related]

  • 13. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
    von Kries R, Siedler A, Schmitt HJ, Reinert RR.
    Clin Infect Dis; 2000 Aug 14; 31(2):482-7. PubMed ID: 10987709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults.
    Gaillat J.
    Med Mal Infect; 2013 Jun 14; 43(6):215-21. PubMed ID: 23769155
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.